Ben Gruenstein Speaks at GIR Live’s Global 2022 Conference
September 20, 2022
On September 16, 2022, Cravath partner Benjamin Gruenstein participated in Global Investigations Review Live’s Global 2022 Conference, which was held from September 15‑16, 2022 in Lisbon, Portugal. Ben spoke on a panel entitled “Self‑Reporting to the Authorities: Negotiating and Securing Deferred Prosecution Agreements (DPAs),” which explored when and how a company should report potential criminal activity, and how to manage the process of securing a DPA and understand different jurisdictional approaches to settling corporate liability.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1999, Harvard Law Schoolmagna cum laude
-
A.B., 1996, Harvard CollegePhi Beta Kappa, summa cum laude
- New York
- District of Columbia
Education
Admitted In
Related News & Insights
Deals & Cases
September 01, 2022
Novartis Directors and Officers Win Dismissal of Shareholder Derivative Suit in New York Supreme Court
On August 19, 2022, the New York Supreme Court Commercial Division issued a decision dismissing a shareholder derivative action filed against current and former directors and officers of Novartis AG (“Novartis”) and several Novartis subsidiaries who, along with the Company, were represented by Cravath. Justice Margaret Chan of the Commercial Division dismissed the suit without prejudice to refile in Basel, Switzerland as required by a forum selection clause contained in Novartis’s Articles of Incorporation.
Deals & Cases
May 02, 2022
Texas Court of Criminal Appeals Stays Execution of Death Row Inmate and Remands Habeas Claims to Trial Court
On April 19, 2022, Cravath, working on a pro bono basis, submitted an amicus brief on behalf of the Innocence Network in support of death row inmate Melissa Lucio’s application for habeas corpus and motion to stay execution. Just two days before the scheduled execution, on April 25, 2022, the Texas Court of Criminal Appeals issued a per curiam opinion staying the execution and remanding the habeas claims to the trial court for a merits review.
